The RAMP® Platform delivers superior sensitivity in the detection of Respiratory Syncytial Virus (RSV) by delivering objective, rapid test results in approximately 15 minutes. Results aid Physicians in making quick clinical decisions and therefore, provide efficient and effective treatment to patients. Rapid detection of RSV, combined with other infection control measures, may help healthcare facilities improve patient care and help protect at-risk populations.

• Positive/Negative Quality Control swabs available
• Approx. 15 minutes per test
• Rapid aid in diagnosis
• Nasal wash/aspirate, nasopharyngeal aspirate or nasopharyngeal swab samples acceptable
• Standardized test procedure for all infectious disease assays
• Qualitative test

The RAMP® RSV test is a qualitative, immunochromatographic test used for the detection of Respiratory Syncytial Virus (RSV) F-protein antigens in nasal wash, nasopharyngeal aspirate and nasopharyngeal swab samples. It is an in vitro diagnostic test that aids in the rapid diagnosis of RSV infections in symptomatic patients 21 years of age and younger.

Positive/Negative controlswabs are available for RAMP RSV tests.

It is an in vitro diagnostic test that aids in the rapid differential diagnosis of influenza viral infections in symptomatic patients.